" /> bioavailabilty - CISMeF





Preferred Label : bioavailabilty;

Detailed label : bioavailabilty in pharmacokinetics;

IUPAC acronym : iv; ev;

IUPAC definition : Ratio of the systemic exposure from extravascular (ev) exposure to that following intravenous (iv) exposure as described by the equation: \[F \frac{A_{{ev}}\ D_{{iv}}}{B_{{iv}}\ D_{{ev}}}\] where F is the bioavailabilty, A and B are areas under the (plasma) concentration-time curve following extravascular and intravenous administration, respectively, and Dev and Div are the administered extravascular and intravenous doses.;

Détails


Vous pouvez consulter :

Ratio of the systemic exposure from extravascular (ev) exposure to that following intravenous (iv) exposure as described by the equation: \[F \frac{A_{{ev}}\ D_{{iv}}}{B_{{iv}}\ D_{{ev}}}\] where F is the bioavailabilty, A and B are areas under the (plasma) concentration-time curve following extravascular and intravenous administration, respectively, and Dev and Div are the administered extravascular and intravenous doses.

Nous contacter.
30/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.